Transient Post-Natal Exposure to Xenoestrogens Induces Long-Term Alterations in Cardiac Calcium Signaling.
calcium signaling
endocrine disruptor
heart
post-natal
programming
Journal
Toxics
ISSN: 2305-6304
Titre abrégé: Toxics
Pays: Switzerland
ID NLM: 101639637
Informations de publication
Date de publication:
23 Feb 2022
23 Feb 2022
Historique:
received:
24
01
2022
revised:
03
02
2022
accepted:
16
02
2022
entrez:
24
3
2022
pubmed:
25
3
2022
medline:
25
3
2022
Statut:
epublish
Résumé
Today, non-communicable disorders are widespread worldwide. Among them, cardiovascular diseases represent the main cause of death. At the origin of these diseases, exposure to challenges during developmental windows of vulnerability (peri-conception, in utero, and early infancy periods) have been incriminated. Among the challenges that have been described, endocrine disruptors are of high concern because of their omnipresence in the environment. Worrisomely, since birth, children are exposed to a significant number of endocrine disruptors. However, the role of such early exposure on long-term cardiac health is poorly described. In this context, based on a model of rats exposed postnatally and transiently to an estrogenic compound prototype (estradiol benzoate, EB), we aimed to delineate the effects on the adult heart of such transient early exposure to endocrine disruptors and identify the underlying mechanisms involved in the potential pathogenesis. We found that this transient post-natal exposure to EB induced cardiac hypertrophy in adulthood, with increased cardiomyocyte size. The evaluation of cardiac calcium signaling, through immunoblot approaches, highlighted decreased expression of the sarcoplasmic reticulum calcium ATPase 2 (SERCA2) and decreased Nuclear Factor of Activated T Cells (NFAT3) phosphorylation as a potential underlying mechanism of cardiac hypertrophy. Furthermore, the treatment of cardiomyocytes with EB in vitro induced a decrease in SERCA2 protein levels. Overall, our study demonstrates that early transient exposure to EB induces permanent cardiac alterations. Together, our data highlight SERCA2 down-regulation as a potential mechanism involved in the cardiac pathogenesis induced by EB. These results suggest programming of adult heart dysfunctions such as arrhythmia and heart failures by early exposure to endocrine disruptors and could open new perspectives for treatment and prevention.
Identifiants
pubmed: 35324727
pii: toxics10030102
doi: 10.3390/toxics10030102
pmc: PMC8954167
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Cardiovasc Toxicol. 2011 Sep;11(3):204-14
pubmed: 21479763
Environ Toxicol. 2017 Mar;32(3):823-831
pubmed: 27189055
J Endocrinol. 2008 Jan;196(1):21-31
pubmed: 18180314
Neurotoxicology. 2018 Dec;69:266-277
pubmed: 30056177
Front Endocrinol (Lausanne). 2019 Mar 01;10:112
pubmed: 30881345
Epigenomics. 2016 Nov;8(11):1459-1479
pubmed: 27762633
Front Cardiovasc Med. 2021 Mar 19;8:592362
pubmed: 33816571
Sci Total Environ. 2020 Jun 25;723:137952
pubmed: 32213405
Redox Biol. 2015 Dec;6:260-271
pubmed: 26296072
Endocrinology. 2012 Apr;153(4):1936-47
pubmed: 22334722
Gene Ther. 2007 Feb;14(3):211-8
pubmed: 17024101
Circ Res. 2017 Jul 7;121(2):181-195
pubmed: 28684623
Reprod Toxicol. 2018 Apr;77:94-102
pubmed: 29476780
Neonatology. 2018;113(4):393-399
pubmed: 29852488
J Transl Med. 2014 Nov 26;12:323
pubmed: 25425099
Circ Res. 2004 Jan 9;94(1):110-8
pubmed: 14656927
Cell Death Discov. 2019 Mar 1;5:71
pubmed: 30854230
J Appl Toxicol. 2015 Nov;35(11):1271-7
pubmed: 26096086
Circulation. 2009 Mar 10;119(9):1241-52
pubmed: 19237664
Acta Physiol (Oxf). 2014 May;211(1):13-6
pubmed: 24612823
Annu Rev Physiol. 2008;70:23-49
pubmed: 17988210
Reprod Toxicol. 2019 Mar;84:114-121
pubmed: 30659930
Heart Fail Rev. 2020 May;25(3):523-535
pubmed: 31701344
J Biol Chem. 2000 Dec 1;275(48):38073-80
pubmed: 10970890
J Dev Orig Health Dis. 2018 Dec;9(6):615-631
pubmed: 29909803
Early Hum Dev. 2014 Sep;90 Suppl 2:S23-4
pubmed: 25220121
Biochim Biophys Acta. 2014 Nov;1843(11):2705-18
pubmed: 25110346
J Cardiol. 2020 Jul;76(1):14-17
pubmed: 32115330
Expert Opin Biol Ther. 2010 Jan;10(1):29-41
pubmed: 20078230
PLoS One. 2011;6(9):e25455
pubmed: 21980463
Am J Physiol Heart Circ Physiol. 2013 Nov 1;305(9):H1344-53
pubmed: 23997093
Am J Physiol Heart Circ Physiol. 2019 Mar 1;316(3):H554-H565
pubmed: 30575439
Best Pract Res Clin Endocrinol Metab. 2021 Sep;35(5):101516
pubmed: 33773932
Lancet Diabetes Endocrinol. 2020 Aug;8(8):703-718
pubmed: 32707118
Med Sci (Paris). 2016 Jan;32(1):15-20
pubmed: 26850602